The FDA gave its stringent PMA approval to Minerva Surgical's Endometrial Ablation System to treat excessive bleeding in premenopausal women that's due to benign causes, and for whom childbearing is ...

Additionally, Minerva ES is a one-time, non-hormonal, incisionless treatment with the recovery time of 1-2 days. "The agreement with Minerva Surgical is important to Blackmaple Group because it ...

Bay Area startup Minerva Surgical has just raised $25 million for its device that treats menorrhagia, or abnormally heavy menstrual bleeding in women, according to a regulatory filing. Minerva is ...

It is a subject that most people don’t want to talk about, but one-third of all women seek treatment for heavy menstrual bleeding at some point in their lives. In Healthy Living we learn how, for some ...

Minerva Surgical, a Bay Area startup developing an ablation device that can curb abnormally heavy menstrual periods, just tacked on another $15 million to its cash reserve, according to a regulatory ...

Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Endometrial Ablation Devices Market - Analysis By Device Type, End-User By Region, By Country (2022 Edition): Market Insights and Forecast with ...

Technology:The company has developed the Minerva Endometrial Ablation System to treat the problem of heavy menstruation in women who are pre-menopausal and do not wish to have more children. The ...

NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients The pivotal study ...

Good day and thank you for standing by. Welcome to the Minerva Surgical Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, ...

Revenue was $13.0 million for the second quarter of 2022, compared to $10.9 million in the first quarter of 2022 and $14.1 million for the second quarter of 2021. We experienced quarterly revenue ...